These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 24735096)

  • 41. Multidrug-Resistant Tuberculosis Treatment Outcomes in Relation to Treatment and Initial Versus Acquired Second-Line Drug Resistance.
    Cegielski JP; Kurbatova E; van der Walt M; Brand J; Ershova J; Tupasi T; Caoili JC; Dalton T; Contreras C; Yagui M; Bayona J; Kvasnovsky C; Leimane V; Kuksa L; Chen MP; Via LE; Hwang SH; Wolfgang M; Volchenkov GV; Somova T; Smith SE; Akksilp S; Wattanaamornkiet W; Kim HJ; Kim CK; Kazennyy BY; Khorosheva T; Kliiman K; Viiklepp P; Jou R; Huang AS; Vasilyeva IA; Demikhova OV; ; Lancaster J; Odendaal R; Diem L; Perez TC; Gler T; Tan K; Bonilla C; Jave O; Asencios L; Yale G; Suarez C; Walker AT; Norvaisha I; Skenders G; Sture I; Riekstina V; Cirule A; Sigman E; Cho SN; Cai Y; Eum S; Lee J; Park S; Jeon D; Shamputa IC; Metchock B; Kuznetsova T; Akksilp R; Sitti W; Inyapong J; Kiryanova EV; Degtyareva I; Nemtsova ES; Levina K; Danilovits M; Kummik T; Lei YC; Huang WL; Erokhin VV; Chernousova LN; Andreevskaya SN; Larionova EE; Smirnova TG
    Clin Infect Dis; 2016 Feb; 62(4):418-430. PubMed ID: 26508515
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Resistance pattern in drug-resistant pulmonary tuberculosis.
    Nagaraja C; Shashibhushan BL; Sagar C; Asif M; Manjunath PH
    J Postgrad Med; 2011; 57(3):181-3. PubMed ID: 21941053
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Body mass index predictive of sputum culture conversion among MDR-TB patients in Indonesia.
    Putri FA; Burhan E; Nawas A; Soepandi PZ; Sutoyo DK; Agustin H; Isbaniah F; Dowdy DW
    Int J Tuberc Lung Dis; 2014 May; 18(5):564-70. PubMed ID: 24903794
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Drug resistant tuberculosis in prisons in Azerbaijan: case study.
    Coninx R; Pfyffer GE; Mathieu C; Savina D; Debacker M; Jafarov F; Jabrailov I; Ismailov A; Mirzoev F; de Haller R; Portaels F
    BMJ; 1998 May; 316(7142):1423-5. PubMed ID: 9572751
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment outcomes for multidrug-resistant tuberculosis under DOTS-Plus: a systematic review and meta-analysis of published studies.
    Kibret KT; Moges Y; Memiah P; Biadgilign S
    Infect Dis Poverty; 2017 Jan; 6(1):7. PubMed ID: 28093078
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Initial drug resistance pattern among pulmonary tuberculosis patients.
    Gupta H; Kant S; Jain A; Natu SM; Ahluwalia S
    Indian J Tuberc; 2013 Jul; 60(3):154-61. PubMed ID: 24000493
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Outcomes of patients with multidrug-resistant pulmonary tuberculosis treated with ofloxacin/levofloxacin-containing regimens.
    Yew WW; Chan CK; Chau CH; Tam CM; Leung CC; Wong PC; Lee J
    Chest; 2000 Mar; 117(3):744-51. PubMed ID: 10713001
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Low enrollment and high treatment success in children with drug-resistant tuberculosis in Ethiopia: A ten years national retrospective cohort study.
    Tola HH; Holakouie-Naieni K; Mansournia MA; Yaseri M; Tesfaye E; Mahamed Z; Molla Sisay M
    PLoS One; 2020; 15(2):e0229284. PubMed ID: 32101580
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diabetes mellitus is associated with cavities, smear grade, and multidrug-resistant tuberculosis in Georgia.
    Magee MJ; Kempker RR; Kipiani M; Gandhi NR; Darchia L; Tukvadze N; Howards PP; Narayan KM; Blumberg HM
    Int J Tuberc Lung Dis; 2015 Jun; 19(6):685-92. PubMed ID: 25946360
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment outcome among cases of multidrug-resistant tuberculosis (MDR TB) in Western India: A prospective study.
    Patel SV; Nimavat KB; Alpesh PB; Shukla LK; Shringarpure KS; Mehta KG; Joshi CC
    J Infect Public Health; 2016; 9(4):478-84. PubMed ID: 26724262
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transmissibility and potential for disease progression of drug resistant
    Becerra MC; Huang CC; Lecca L; Bayona J; Contreras C; Calderon R; Yataco R; Galea J; Zhang Z; Atwood S; Cohen T; Mitnick CD; Farmer P; Murray M
    BMJ; 2019 Oct; 367():l5894. PubMed ID: 31649017
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A Survival Analysis of Successful and Poor Treatment Outcome Among Patients with Drug-Resistant Tuberculosis and the Associated Factors: A Retrospective Cohort Study.
    Machmud PB; Gayatri D; Ronoatmodjo S
    Acta Med Indones; 2021 Apr; 53(2):184-193. PubMed ID: 34251347
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Factors associated with treatment success and death in cases with multidrug-resistant tuberculosis in Bulgaria, 2009-2010.
    Milanov V; Falzon D; Zamfirova M; Varleva T; Bachiyska E; Koleva A; Dara M
    Int J Mycobacteriol; 2015 Jun; 4(2):131-7. PubMed ID: 26972881
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Assessment of Factors Associated with Unfavorable Outcomes among Drug-Resistant TB Patients: A 6-Year Retrospective Study from Pakistan.
    Khan FU; Rehman AU; Khan FU; Hayat K; Khan A; Ahmad N; Chang J; Malik UR; Fang Y
    Int J Environ Res Public Health; 2022 Jan; 19(3):. PubMed ID: 35162598
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Loss-To-Follow-Up on Multidrug Resistant Tuberculosis Treatment in Gujarat, India: The WHEN and WHO of It.
    Shringarpure KS; Isaakidis P; Sagili KD; Baxi RK
    PLoS One; 2015; 10(7):e0132543. PubMed ID: 26167891
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genotype analysis of ofloxacin-resistant multidrug-resistant
    Gupta A; Sinha P; Rathod S; Shanmugam SK; Uma Devi KR; Anupurba S; Nema V
    Indian J Med Res; 2020 Apr; 151(4):361-370. PubMed ID: 32461400
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Profile and response to anti-tuberculosis treatment among elderly tuberculosis patients treated under the TB Control programme in South India.
    Velayutham BR; Nair D; Chandrasekaran V; Raman B; Sekar G; Watson B; Charles N; Malaisamy M; Thomas A; Swaminathan S
    PLoS One; 2014; 9(3):e88045. PubMed ID: 24618888
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment outcomes of drug-resistant tuberculosis in the Netherlands, 2005-2015.
    Pradipta IS; Van't Boveneind-Vrubleuskaya N; Akkerman OW; Alffenaar JC; Hak E
    Antimicrob Resist Infect Control; 2019; 8():115. PubMed ID: 31338162
    [TBL] [Abstract][Full Text] [Related]  

  • 59. National survey of drug-resistant tuberculosis in China.
    Zhao Y; Xu S; Wang L; Chin DP; Wang S; Jiang G; Xia H; Zhou Y; Li Q; Ou X; Pang Y; Song Y; Zhao B; Zhang H; He G; Guo J; Wang Y
    N Engl J Med; 2012 Jun; 366(23):2161-70. PubMed ID: 22670902
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comorbidities and treatment outcomes in multidrug resistant tuberculosis: a systematic review and meta-analysis.
    Samuels JP; Sood A; Campbell JR; Ahmad Khan F; Johnston JC
    Sci Rep; 2018 Mar; 8(1):4980. PubMed ID: 29563561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.